All News

Filter News

Filter by

News Type
Topic
Language
Published Date

Filter by News Type

Done

Filter by Topic

Done

Filter by Language

Done

Filter by Published Date

Done
Showing 10 out of 203 results
human heart anatomy
|
Research Feature
Is the randomized registry trial the next “disruptive technology” in clinical research? That is the question posed and discussed by Dr. Michael Lauer , director of the NHLBI’s Division of Cardiovascular Sciences, and co-author Dr. Ralph B. D’Agostino from Boston University and the Harvard Clinical Research Institute in their recent New England...
Toddler, held by an adult, being examined by a medical professional
|
Research Feature
iStock_000022543507XSmall.jpg
Each year, almost 1 percent of all newborns –about 35,000 babies—enter this world with a congenital heart defect. In some cases the defect is minor and causes no complications, but other times these defects can be serious or even life threatening. Given the powerful responses children in...
|
Research Feature
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has launched an $87.2 million international research program to extend a highly successful program assessing blood banking and transfusion medicine. Research conducted under the seven-year program will focus on improving transfusion benefits and reducing its...
Blood cells
|
Research Feature
The NHLBI and Sickle Cell Disease The NHLBI has researched sickle cell disease since its founding as the National Heart Institute in 1948. Since 1972, when the National Sickle Cell Anemia Control act was passed, the NHLBI has spent more than $1 billion researching the condition. The NHLBI funds basic research and large clinical trials and conducts...
human heart anatomy green
|
Research Feature
Gene Scan IDs Heart Disease Risk
dnalook.jpg
High blood cholesterol and triglycerides are known risk factors for heart disease. However, it is unclear how much of the risk for either is inherited. To address this question, scientists analyzed DNA from more than 100,000 people in a search for genetic...
scientist using pipette microscope
|
Research Feature
Nine studies focus on heart, lung, and blood diseases The National Institutes of Health has funded nine new studies that will develop induced pluripotent stem cells , or iPS cells, from patients with genetic variations that have been associated with coronary artery disease, pulmonary hypertension, clotting disorders, diabetes, and other conditions...
Researcher working with lab equipment.
|
Research Feature
The National Heart, Lung, and Blood Institute (NHLBI) has launched a program to help translate basic discoveries into successful treatments. The Science Moving towArds Research Translation and Therapy program, or SMARTT, will support the transition of potential new therapies for heart, lung, and blood diseases from discovery in the lab to the...
|
Research Feature
Scientific advances that benefit the public health are only as good as their ability to reach the public. Oftentimes, though, the people most at need for those interventions and advances–such as inner city African-American communities—are also the most difficult to reach.
Powell-Wiley profile w caption.jpg
Dr. Tiffany Powell...
|
Research Feature
pulmonaryhypertension.jpg
Pulmonary hypertension is a disease in which pressure rises in the arteries that carry oxygen-poor blood from the heart to the lungs. Symptoms include shortness of breath during light physical activity (for example, climbing a flight of stairs), tiredness, chest pain, and a racing heartbeat. As...
|
Research Feature
The human heart is an amazing biological machine controlled by an internal electrical system that produces about 100,000 beats a day. When abnormal electrical activity causes the heart to beat too quickly, too slowly, or erratically, the condition is called an arrhythmia . Although most arrhythmias are harmless, some can interfere with the heart's...